Yahoo Web Search

    • Endo Completes Acquisition of BioSpecifics

      Morningstar· 3 days ago

      ... received a royalty stream from Endo related to Endo's collagenase-based therapies, which currently include XIAFLEX, marketed by Endo Pharmaceuticals, for the treatment of Dupuytren's contracture and Peyronie's disease, and QWO, the first FDA-approved injectable treatment for cellulite, which is...